Doctors warn against off-label use of new Alzheimer's drug for cerebral amyloid angiopathy
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy ...
Jul 6, 2021
0
5